Author:
Kow Chia Siang,Ramachandram Dinesh Sangarran,Hasan Syed Shahzad
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Tan SY, Cronin H, Byrne S et al (2021) Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings [published online ahead of print, 2021 Jun 22]. Ir J Med Sci. https://doi.org/10.1007/s11845-021-02649-5
2. Cosentino F, Grant PJ, Aboyans V et al (2020) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD [published correction appears in Eur Heart J. 2020 Dec 1;41(45):4317]. Eur Heart 41(2):255–323
3. Hybiak J, Broniarek I, Kiryczyński G et al (2020) Aspirin and its pleiotropic application. Eur J Pharmacol 866:172762
4. Rizk JG, Lavie CJ, Gupta A (2021) Low-dose aspirin for early COVID-19: does the early bird catch the worm? Expert Opin Investig Drugs 30(8):785–788
5. Kow CS, Hasan SS (2021) Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. J Thromb Thrombolysis 52(1):124–129
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献